Medtronic Announces Commencement of Pivotal Study of First Predictive Low Glucose Mgmt Technology for People with Diabetes
October 14, 2014 at 08:06 AM EDT
Medtronic, Inc. (NYSE: MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) ...
